Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
News

Connecting Canadians with neuromuscular disease to research

Erin Russell
CMAJ August 06, 2013 185 (11) E522; DOI: https://doi.org/10.1503/cmaj.109-4512
Erin Russell
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

A scant two years after launching, the Canadian Neuromuscular Disease Registry (CNDR) has data from 1381 registrants and has provided information to researchers on nine occasions. The national patient registry, a collaborative effort by over 40 clinicians and investigators, aims to improve the lives of patients affected by neuromuscular diseases by facilitating research, providing information about clinical trials and improving clinical care through standardization.

The CNDR is recruiting patients across Canada diagnosed with one of the over 40 different neuromuscular diseases, including inherited, inflammatory and degenerative conditions. Registering does not mean automatic recruitment into any particular clinical trial; the onus is always on the patient to contact the study investigators.

Individual neuromuscular diseases are rare, but as a group, they are not uncommon. The overall prevalence of disabling inherited neuromuscular disease presenting in childhood or in later life has been estimated at 1 in 3500.

The development of the registry was led by Dr. Lawrence Korngut from the University of Calgary in Alberta, Dr. Craig Campbell from Western University in London, Ontario, and Megan Johnston from the University of Calgary.

Korngut, the CNDR national principal investigator, stated in an email that patients have responded very positively to the registry. “The opportunity to potentially access information about research studies is highly valued among patients with neuromuscular diseases.” While many patients know of registries internationally, they feel more comfortable participating in a registry that is Canadian and complies with Canadian privacy standards, he added.

Shelagh Mikulak, a registrant who has amyotrophic lateral sclerosis (ALS) stated in a registry press release that she joined the registry because it gives her hope that, “with the information available to researchers there will be significant increase in the number of studies leading to discovering the cause, treatment and cure of ALS.”

Figure

The Canadian Neuromuscular Disease Registry is recruiting patients across Canada diagnosed with one of the over 40 different neuromuscular diseases.

Image courtesy of © 2013 Thinkstock

In an effort to balance the quality and the comprehensiveness of the registry, detailed data are only collected on selected, so-called “index disease” patients who regularly visit a participating clinic. There are currently 691 “index disease” registrants at 20 academic and neuromuscular clinics in six provinces. Clinicians and investigators at four additional sites are preparing to join the registry. If successful, the registry will have participating clinics in eight provinces.

Patients who do not live in cities with affiliated clinics are able to register as “non-index disease” patients by contacting the CNDR national office at the University of Calgary, Alberta. Those in the “non-index disease” category provide only their contact information and confirmation of disease diagnosis. The registry has registrants from 12 of the 13 provinces and territories. The long-term goal is to have clinics in every province and territory.

The registry has been funded through contributions by the ALS Society of Canada, Jesse’s Journey, the Families of Spinal Muscular Atrophy Canada Society and the Marigold Foundation. Research projects using data from the registry are independently funded.

Korngut says, “Though early, the CNDR is already facilitating research and is attracting clinical trials to Canada.”

Dr. Sanjay Kalra from the University of Alberta in Edmonton, has received funding from the Canadian Institutes of Health Research for a project on magnetic resonance imaging biomarkers in ALS. While the project would have been possible without the existence of the CNDR, Kalra stated in an email that it would have taken “considerable resources to develop the data management infrastructure that is ready and provided by the CNDR.” Kalra also credits the existence of the registry with strengthening his team’s grant application to the Canadian Institutes of Health Research.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (11)
CMAJ
Vol. 185, Issue 11
6 Aug 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Connecting Canadians with neuromuscular disease to research
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Connecting Canadians with neuromuscular disease to research
Erin Russell
CMAJ Aug 2013, 185 (11) E522; DOI: 10.1503/cmaj.109-4512

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Connecting Canadians with neuromuscular disease to research
Erin Russell
CMAJ Aug 2013, 185 (11) E522; DOI: 10.1503/cmaj.109-4512
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Saying goodbye to CMAJ News
  • National survey highlights worsening primary care access
  • How Canadian hospitals are decreasing carbon emissions
Show more News

Similar Articles

Collections

  • Topics
    • Neurology
    • Patient education

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire